RadNet (RDNT) Stock: Buy, Sell, or Hold?

RDNT - RadNet, Inc. Common Stock

SERVICES-MEDICAL LABORATORIES
$68.94
-1.71 (-2.42%) ▼
5d: -5.83%
30d: -9.07%
90d: +5.06%
WAIT
LOW Confidence
Protect Your RDNT Gains
Analysis Updated: Sep 30, 2026 12:00 AM ET
Earnings: Nov 09, 2026

Get Alerted When RDNT Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 MIXED SIGNALS: RDNT shows conflicting indicators. Wait for confirmation before entering.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$43.17
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$26.80
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: RDNT is currently trading at $68.94, which is considered oversold relative to its 30-day fair value range of $71.88 to $76.38. The stock's valuation (Forward PE: 77.8) is in line with its historical norms (74.1). At these levels, the market is pricing in 1.6% annual earnings growth.

Technical Outlook: Technically, RDNT is showing support break momentum. The price is currently testing key support at $68.94. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: RDNT scores 26/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $94.62 (+37.3%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $71.88 - $76.38
Company Quality Score 49/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 68.1%

Protect Your Profits

Holding RDNT? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Options cheap (IV 0th percentile)
  • BEARISH: Weak technical setup (26/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 37.3% below Wall St target ($94.62)
  • BULLISH: Expecting earnings turnaround to 1.6% growth with 25.0% revenue growth
  • WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $71.88 - $76.38
Current vs Trading Range OVERSOLD
Expected Move (7 Days) ±$4.18 (6.1%)

Support & Resistance Levels

Support Level $68.94
Resistance Level $78.01
Current Trend Support Break
Technical data as of Sep 30, 2026

Fundamental Context

Forward P/E (Next Year Est.) 77.75
Wall Street Target $94.63 (+37.3%)
Revenue Growth (YoY) 25.0%
Earnings Growth (YoY) -49.1%
Profit Margin -0.9%
Valuation Premium vs History +1.6% premium
PE vs Historical 77.8 vs 74.1 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +1.6% (market-implied from PE analysis)
1-Year Target $70.04 (+2%)
2-Year Target $71.16 (+3%)
3-Year Target $72.30 (+5%)
3-Yr Target (if PE normalizes) (PE: 78→74) PE COMPRESSION $68.91 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 77.7, Growth: 72.4%) $232.67 (+238%)
Base: (SPY PE: 20.4, Growth: 72.4%) $61.05 (-11%)
Bear: (PE: 17.3, Growth: 72.4%) $51.89 (-25%)
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: September 30, 2026 5:12 PM ET
Data refreshes hourly during market hours. Next update: 6:12 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for RDNT.

Create Free Account

Already have an account? Log In

Top Rated Diagnostics & Research Stocks

Top-rated stocks in Diagnostics & Research by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
EXAS
EXACT Sciences Corporati…
STRONG BUY
26 analysts
$106 52 HOLD
TMO
Thermo Fisher Scientific…
STRONG BUY
31 analysts
$653 34 SELL
GH
Guardant Health Inc
STRONG BUY
23 analysts
$196 46 HOLD
DHR
Danaher Corporation
STRONG BUY
25 analysts
$231 35 SELL
LH
Laboratory Corporation o…
STRONG BUY
20 analysts
$345 67 BUY

Advanced RDNT Option Strategies

Professional options setups generated by AI based on today's RDNT price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for RDNT

RDNT Technical Chart RDNT Price Prediction RDNT Earnings Date Why is RDNT Moving Today? RDNT Investment Advisor RDNT Fair Price Analyzer RDNT Options Advisor RDNT Options Chain RDNT Options Analysis RDNT Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals